The Department of Health and Human Services updated its guidance and FAQs regarding the agency’s request for daily COVID-19-related hospital data reporting.
News
Latest
The FBI today alerted the private sector to a sophisticated and aggressive nation-state campaign targeting known critical and common vulnerabilities in virtual private networks, initially reported by the government last year.
The AHA issued a Regulatory Advisory with a summary of the July 31 Centers for Medicare & Medicaid Services’ final rule for the inpatient psychiatric facility prospective payment system for fiscal year 2021.
The National Academies of Sciences, Engineering, and Medicine will host webinars on crisis standards of care and COVID-19 data applications for state and local decision-making during the pandemic.
The Centers for Medicare & Medicaid Services resumed the five-state Review Choice Demonstration for Home Health Services, ending a pause initiated March 29 due to the COVID-19 pandemic.
The National Institutes of Health’s Rapid Acceleration of Diagnostics initiative awarded $248.7 million in contracts to produce four new laboratory tests and three new point-of-care tests to detect SARS-CoV-2.
The Department of Health and Human Services extended to Aug. 28 the deadline for eligible Medicaid, Children’s Health Insurance Program and dental providers to apply for $15 billion in Provider Relief Funds available through the Phase 2 general distribution to these providers.
A Renewed Call to Dare All for Our Country
In this two-part Trustee Insights podcast, senior health leaders discuss challenges board members can expect to encounter as they strive for health equity and how best to meet them.
The AHA’s American Society for Health Care Risk Management this month released the second in a series of white papers for providers managing patients with behavioral health disorders beyond the inpatient setting.
The House of Representatives voted 217-197 to approve six appropriations bills, including legislation that would provide $196.5 billion in funding for the departments of Labor, Health and Human Services, and Education in fiscal year 2021.
The Centers for Medicare & Medicaid Services seeks input on rulemaking to require electronic prescribing for controlled substances covered by Medicare Part D and Medicare Advantage prescription drug plans beginning Jan. 1, in accordance with the Substance Use-Disorder Prevention that Promotes Opioid Recover and Treatment for Patients and Communities Act of 2018.
The U.S. Court of Appeals for the District of Columbia Circuit overturned a 2018 district court decision that found the Department of Health and Human Services exceeded its statutory authority when it reduced 2018 and 2019 Medicare payment rates for many hospitals in the 340B Drug Pricing Program by nearly 30%.
The Centers for Disease Control and Prevention Aug. 3 at 3 p.m. ET will hold a webinar with updates on the COVID-19 response, including new resources for businesses and other private-sector organizations.
Loretto Hospital, serving Chicago’s Austin community on the city’s West Side, faces growing financial and staffing pressures while delivering care to a majority Black population in a designated COVID-19 hotspot.
The American Society of Association Executives awarded a 2020 “Power of A” Award to the AHA, The Creative Coalition and the Association for Healthcare Philanthropy for their integrated “Protect the Heroes” campaign.
A study released by the Centers for Disease Control and Prevention demonstrates that SARS-CoV-2 spreads efficiently in youth-centric settings, resulting in high attack rates among persons in all age groups.
The Food and Drug Administration updated its FAQs on the emergency use authorization of remdesivir for use on certain hospitalized COVID-19 patients. The document includes information on the changes to Gilead’s fact sheets for health care providers and patient caregivers.
President Trump announced a national call to action and campaign to encourage individuals who recover from COVID-19 to donate their plasma, which may contain antibodies that could help other patients fight the virus. As part of the effort, the Department of Health and Human Services released several public service announcements featuring public health experts.
The Department of Health and Human Services announced that it will partner with the Department of Defense to fund the advanced development — including clinical trials and large-scale manufacturing — of a COVID-19 investigational vaccine from Sanofi and GlaxoSmithKline.